Morrish; Glynn
Patent Applications and Registrations
Patent applications and USPTO patent grants for Morrish; Glynn.The latest application filed is for "novel dosing regimens of celgosivir for the treatment of dengue".
- Morrish; Glynn - Toowong AU
| Patent | Date |
|---|---|
| Dosing regimens of celgosivir for the treatment of dengue Grant 11,219,616 - Dow , et al. January 11, 2 | 2022-01-11 |
| Novel Dosing Regimens of Celgosivir for the Treatment of Dengue App 20200338050 - Dow; Geoffrey S. ; et al. | 2020-10-29 |
| Dosing regiments of celgosivir for the treatment of dengue Grant 10,517,854 - Dow , et al. Dec | 2019-12-31 |
| Novel Dosing Regimens of Celgosivir for the Treatment of Dengue App 20180064693 - Dow; Geoffrey S. ; et al. | 2018-03-08 |
| Dosing regimens of celgosivir for the treatment of dengue Grant 9,763,921 - Dow , et al. September 19, 2 | 2017-09-19 |
| Novel Dosing Regimens of Celgosivir for the Treatment of Dengue App 20160030403 - DOW; Geoffrey S. ; et al. | 2016-02-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 